基于TLR4NF-κB信号通路探究心脉康改善兔动脉粥样硬化的机制

基于TLR4/NF-κB信号通路探究心脉改善兔动脉粥样硬化的机制
作者:周智慧 陈贺 吴锦波 叶小汉
来源:《中国药房》2021年第22期
万能夹具
        中图分类号 R972 文献标志码 A 文章编号 1001-0408(2021)22-2736-07
        DOI 10.6039/j.issn.1001-0408.2021.22.09
        摘 要 目的:探究心脉康改善兔动脉粥样硬化(AS)的机制。方法:将50只雄性新西兰兔随机分为假手术组、模型组、辛伐他汀组[阳性对照,2.60 mg/(kg·d)]和心脉康低、高剂量组[0.21、0.84 g/(kg·d)],每组10只。假手术组兔给予普通饲料喂养,只分离结扎股动脉但不损伤腹主动脉内皮;其余各组兔均给予高脂饲料喂养并行腹主动脉内膜球囊损伤术以复制AS模型。术后10周,假手术组和模型组兔均灌胃生理盐水,各药物组兔灌胃相应药液(溶剂均为生理盐水),给药体积为100 mL,每天给药1次,连续12周。末次给药后,观察各组兔腹主动脉及内壁的病理变化,检测血清中三酰甘油(TG)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)以及白细胞介素6(IL-6)、IL-1β含量,检测腹主动脉组织中Toll样受体4(TLR4)、核因子κB p65(NF-κB p65)含量及其蛋白表达水平。结果:与假手术组比较,模型组兔腹主动脉管腔内膜富含脂质,管壁厚度和斑块面积明显增加,可见明显的血管内皮损伤;血清中TG、TC、LDL-C、IL-6、IL-1β含量和腹主动脉组织中TLR4、NF-κB p65含量及其蛋白表达水平均显著升高,HDL-C含量显著降低(P短期负荷预测
        关键词 心脉康;动脉粥样硬化;Toll样受体家族4/核因子κB信号通路;血脂代谢;炎症反应;兔
        Study on Mechanism of the Improvement Effects of Xinmaikang on Atherosclerosis in Rabbits Based on TLR4/NF-κB Signaling Pathway
        ZHOU Zhihui1,CHEN He2,WU Jinbo1,YE Xiaohan1(1. Dept. of Cardiology, Dongguan Hospital, Guangzhou University of TCM, Guangdong Dongguan 523015, China; 2. The First Clinical Medical College, Guangzhou University of TCM, Guangzhou 510405, China)
        ABSTRACT OBJECTIVE: To explore the mechanism of Xinmaikang improving atherosclerosis (AS) in rabbits. METHODS: A total of 50 male Zealand rabbits were randomly divided into sham operation group, model group, simvastatin group [positive control, 2.60 mg/(kg·d)] and Xinmaikang low-dose and high-dose groups [0.21, 0.84 g/(kg·d)], with 10 rabbits in each group. Rabbits in sham operation group were fed with ordinary diet, and only femoral artery was separated and ligated, and abdominal aortic endothelium was not strained; the other groups were given high-fat diet and received abdominal aortic intimal balloon injury to induce AS model. Ten weeks after
operation, sham operation group and model group were given intragastric administration of normal saline, and administration groups were given corresponding drug solution intragastrically (normal saline as solvent) with the volume of 100 mL, once a day, for consecutive 12 weeks. After last administration, the pathological changes of abdominal aorta and inner wall in rabbits were observed in each group. The serum contents of triglyceride (TG), total cholesterol (TC), low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C), interleukin-6(IL-6) and IL-1β were detected, and the contents and protein expression of Toll-like receptor 4 (TLR4) and nuclear factor-κB p65 (NF-κB p65) in abdominal aortic tissue were determined. RESULTS: Compared with sham operation group, the intima of abdominal aorta in model group was rich in lipids, the thickness of vessel wall and plaque area were increased obviously, and there was obvious vascular endothelial injury. The contents of TG, TC, LDL-C, IL-6 and IL-1β in serum, the contents and protein expression of TLR4 and NF-κB p65 in abdominal aorta tissue were significantly increased, while the content of HDL-C was decreased significantly (P
        KEYWORDS Xinmaikang; Atherosclerosis; TLR4/NF-κB signaling pathway; Lipid metabolism; Inflammatory response; Rabbit
智力积木
        动脉粥样硬化(AS)是动脉硬化性血管疾病中重要且常见的一种,是多种心脑血管疾病(如冠心病、血栓栓塞性疾病和脑血管病等)的病理基础[1]。进入21世纪以来,全球AS的发病率呈逐年上升趋势,对人类健康造成了严重威胁[2]。AS的发病机制尚未明确。近年来,多项研究提示,慢性炎症在AS的发生发展中发挥着重要作用[3-4]。Toll样受体4(TLR4)作为Toll样受体家族(TLRs)中的一员,与配体结合后能够促进核因子κB(NF-κB)发生核转移,从而激活下游炎症因子参与到AS的各个阶段,故抑制TLR4/NF-κB信号通路可能是改善AS的潜在机制之一[5-6]。
        现代医学对AS的方法包括手术与药物,但二者均存在一定的局限性,如患者经皮冠状动脉腔内成形术后易发生再狭窄,长期服用他汀类药物会对其肝脏、肌肉、肾脏以及糖代谢等造成负面影响,二者联合则可能引发横纹肌溶解[7-8]。中医认为,AS属本虚标实之证,阴虚、阳虚、气虚为本,血瘀、痰浊、气滞、热毒、寒凝为标,可归“脉痹”“积聚”的范畴[9]。心脉康由广州中医药大学东莞医院叶小汉教授创方,以鳖甲、三棱、
稳压电源模块莪术、枳实、制胆星和石斛等药材组成,具有软坚散结、益气通脉的功效[10]。临床研究证实,心脉康对AS患者具有显著的作用[11-12],但其分子机制尚未明确。本研究通过观察心脉康对兔AS的影响,基于TLR4/NF-κB信号通路探究其改善兔AS的作用机制,旨在为心脉康的机制研究提供参考。沟槽式管接头
        1 材料排屑装置
        1.1 主要仪器
        本研究所用主要仪器包括BX41TF型光学显微镜(日本Olympus公司)、LEO-1430VP型扫描电子显微镜(德国Zeiss公司)、Modular P800型全自动生化分析仪(瑞士Roche公司)、BondmaX型全自动免疫组化染机(德国Leica公司)、Power Wave XS2型酶标仪(美国BioTek公司)、JS-680A型自动凝胶成像分析仪(上海培清科技有限公司)等。

本文发布于:2024-09-21 13:32:57,感谢您对本站的认可!

本文链接:https://www.17tex.com/tex/1/254594.html

版权声明:本站内容均来自互联网,仅供演示用,请勿用于商业和其他非法用途。如果侵犯了您的权益请与我们联系,我们将在24小时内删除。

标签:心脉   主动脉   治疗   改善   机制
留言与评论(共有 0 条评论)
   
验证码:
Copyright ©2019-2024 Comsenz Inc.Powered by © 易纺专利技术学习网 豫ICP备2022007602号 豫公网安备41160202000603 站长QQ:729038198 关于我们 投诉建议